Financhill
Sell
31

INFU Quote, Financials, Valuation and Earnings

Last price:
$5.80
Seasonality move :
2.97%
Day range:
$5.47 - $5.87
52-week range:
$5.29 - $9.97
Dividend yield:
0%
P/E ratio:
57.50x
P/S ratio:
0.92x
P/B ratio:
2.10x
Volume:
186.3K
Avg. volume:
138.9K
1-year change:
-38.04%
Market cap:
$120.8M
Revenue:
$134.9M
EPS (TTM):
$0.10

Earnings Data

Next earnings date for INFU
May 09
2025
Most recent earnings per share
$0.04
Missed by $0.02
(Mar 4/2025)
Consensus Estimate
$0.06
(Mar 4/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

INFU Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/09/2025 Q1 $33.8M -- -- -$0.03 --
03/04/2025 Q4 $34.9M $33.8M $0.04 $0.06 -$0.02
11/07/2024 Q3 $34.5M $35.3M $0.08 $0.05 $0.03
08/08/2024 Q2 $33.2M $33.7M $0.03 -- --
05/09/2024 Q1 $31.6M $32M -$0.05 -- --
03/14/2024 Q4 $30M $31.8M $0.00 $0.05 -$0.05
11/07/2023 Q3 -- -- $0.03 $0.09 -$0.06
06/30/2023 Q2 -- -- $0.02 $0.08 -$0.06
03/31/2023 Q1 -- -- -$0.02 $0.06 -$0.08
12/31/2022 Q4 -- -- $0.01 $0.09 -$0.08
09/30/2022 Q3 -- -- $0.02 $0.01 $0.01
06/30/2022 Q2 -- -- -$0.01 -$0.02 $0.01
03/31/2022 Q1 -- -- -$0.02 -- --
12/31/2021 Q4 -- -- $0.02 -- --
09/30/2021 Q3 -- -- -$0.02 -- --
06/30/2021 Q2 -- -- $0.04 -- --
03/31/2021 Q1 -- -- $0.03 -- --
12/31/2020 Q4 -- -- $0.49 -- --
09/30/2020 Q3 -- -- $0.14 -- --
06/30/2020 Q2 -- -- $0.19 -- --
03/31/2020 Q1 -- -- -$0.02 -- --
12/31/2019 Q4 -- -- $0.04 -- --
09/30/2019 Q3 -- -- $0.05 -- --
06/30/2019 Q2 -- -- $0.02 -- --
03/31/2019 Q1 -- -- -$0.05 -- --
12/31/2018 Q4 -- -- -$0.01 -- --
09/30/2018 Q3 -- -- -$0.03 -- --
06/30/2018 Q2 -- -- -$0.02 -- --
03/31/2018 Q1 -- -- $0.01 -- --
12/31/2017 Q4 -- -- -$0.79 -- --
09/30/2017 Q3 -- -- -$0.01 -- --
06/30/2017 Q2 -- -- -$0.05 -- --
03/31/2017 Q1 -- -- -$0.07 -- --
12/31/2016 Q4 -- -- -$0.02 -- --
09/30/2016 Q3 -- -- $0.00 -- --
06/30/2016 Q2 -- -- $0.01 -- --
03/31/2016 Q1 -- -- $0.00 -- --
12/31/2015 Q4 -- -- $0.09 -- --
09/30/2015 Q3 -- -- $0.05 -- --
06/30/2015 Q2 -- -- $0.03 -- --
03/31/2015 Q1 -- -- -$0.02 -- --

InfuSystems Holdings Earnings Questions

  • How Much did InfuSystems Holdings Generate in Revenue Last Quarter?

    InfuSystems Holdings reported $33.8M worth of top line sales in its most recent quarter.

  • Did InfuSystems Holdings Beat Earnings Last Quarter?

    InfuSystems Holdings announced earnings per share of $0.04 which represents a miss of analyst forecast a $0.06 per share.

  • Is InfuSystems Holdings Profitable?

    InfuSystems Holdings reported $18.2M that represents $0.84 per share over the last quarter.

  • What is the Analyst Consensus for InfuSystems Holdings EPS Next Year?

    InfuSystems Holdings's earnings are forecast to grow from $0.11 per share to $0.13 per share next year representing an increase of 36.36%.

  • When is InfuSystems Holdings's Earnings Date?

    InfuSystems Holdings's next earnings date is May 9, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 18

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock